Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies
Grant Award Details
Grant Type:
Grant Number:
PDEV-19154
Investigator(s):
Award Value:
$7,500,000
Status:
Pre-Active
Grant Application Details
Application Title:
